A Novel lncRNA HOXC-AS3 Acts as a miR-3922-5p Sponge to Promote Breast Cancer Metastasis

References

• DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64(1):52–62. doi:10.3322/caac.21203.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30. doi:10.3322/caac.21332.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338.
   PubMed Web of Science ®Google Scholar
• Eiro N, Gonzalez LO, Fraile M, Cid S, Schneider J, Vizoso FJ. Breast cancer tumor stroma: cellular components, phenotypic heterogeneity, intercellular communication, prognostic implications and therapeutic opportunities. Cancers. 2019;11(5):664. doi:10.3390/cancers11050664.
   Web of Science ®Google Scholar
• Venema CM, Bense RD, Steenbruggen TG, Nienhuis HH, Qiu S-Q, van Kruchten M. Consideration of breast cancer subtype in targeting the androgen receptor. Pharmacol Therapeut. 2019;200:135–147. doi:10.1016/j.pharmthera.2019.05.005.
   PubMed Web of Science ®Google Scholar
• Wang G, Liu C, Deng S, Zhao Q, Li T, Qiao S, et al. Long noncoding RNAs in regulation of human breast cancer. Brief Funct Genomics. 2016;15(3):222–226. doi:10.1093/bfgp/elv049.
   PubMed Web of Science ®Google Scholar
• Renganathan A, Felley-Bosco E. Long noncoding RNAs in cancer and therapeutic potential. Adv Exp Med Biol. 2017;1008:199–222. doi:10.1007/978-981-10-5203-3_7.
   PubMed Web of Science ®Google Scholar
• Zhao W, Geng D, Li S, Chen Z, Sun M. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. Cancer Med. 2018;7(3):842–855. doi:10.1002/cam4.1353.
   PubMed Web of Science ®Google Scholar
• Pawlowska E, Szczepanska J, Blasiak J. The long noncoding RNA HOTAIR in breast cancer: does autophagy play a role? Int J Mol Sci. 2017;18(11). doi:10.3390/ijms18112317.
   Web of Science ®Google Scholar
• Dong H, Wang W, Chen R, Zhang Y, Zou K, Ye M, et al. Exosome-mediated transfer of lncRNA‑SNHG14 promotes trastuzumab chemoresistance in breast cancer. Int J Oncol. 2018;53(3):1013–1026. doi:10.3892/ijo.2018.4467.
   PubMed Web of Science ®Google Scholar
• Gooding AJ, Zhang B, Jahanbani FK, Gilmore HL, Chang JC, Valadkhan S, et al. The lncRNA BORG drives breast cancer metastasis and disease recurrence. Sci Rep. 2017;7(1):12698. doi:10.1038/s41598-017-12716-6.
   PubMed Web of Science ®Google Scholar
• Lu G, Li Y, Ma Y, Lu J, Chen Y, Jiang Q, et al. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis. J Exp Clin Cancer Res. 2018; 37(1):289. doi:10.1186/s13046-018-0945-6.
   PubMed Web of Science ®Google Scholar
• Liu R, Wang L, Gan T, Pan T, Huang J, Bai M. Long noncoding RNA LINC00511 promotes cell growth and invasion in triple-negative breast cancer by interacting with Snail. Cancer Manag Res. 2019;11:5691–5699. doi:10.2147/CMAR.S203455.
   PubMed Web of Science ®Google Scholar
• Li XY, Zhou LY, Luo H, Zhu Q, Zuo L, Liu GY, et al. The long noncoding RNA MIR210HG promotes tumor metastasis by acting as a ceRNA of miR-1226-3p to regulate mucin-1c expression in invasive breast cancer. Aging. 2019;11(15):5646–5665. doi:10.18632/aging.102149.
   PubMedGoogle Scholar
• Zhang Y, Zhu M, Sun Y, Li W, Wang Y, Yu W. Upregulation of lncRNA CASC2 suppresses cell proliferation and metastasis of breast cancer via inactivation of the TGF-β signaling pathway. Oncol Res. 2019;27(3):379–387. doi:10.3727/096504018X15199531937158.
   PubMed Web of Science ®Google Scholar
• Gao Z, Wang H, Li H, Li M, Wang J, Zhang W, et al. Long non-coding RNA CASC2 inhibits breast cancer cell growth and metastasis through the regulation of the miR-96-5p/SYVN1 pathway. Int J Oncol. 2018;53(5):2081–2090. doi:10.3892/ijo.2018.4522.
   PubMed Web of Science ®Google Scholar
• Li Z, Li Y, Li Y, Ren K, Li X, Han X, et al. Long non-coding RNA H19 promotes the proliferation and invasion of breast cancer through upregulating DNMT1 expression by sponging miR-152. J Biochem Mol Toxicol. 2017;31(9):e21933. doi:10.1002/jbt.21933.
   Web of Science ®Google Scholar
• Collette J, Le Bourhis X, Adriaenssens E. Regulation of human breast cancer by the long non-coding RNA H19. Int J Mol Sci. 2017;18(11). doi:10.3390/ijms18112319.
   PubMed Web of Science ®Google Scholar
• Zhang E, He X, Zhang C, Su J, Lu X, Si X, et al. A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1. Genome Biol. 2018;19(1):154. doi:10.1186/s13059-018-1523-0.
   PubMed Web of Science ®Google Scholar
• Kasinski AL, Slack FJ. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer. 2011;11(12):849. doi:10.1038/nrc3166.
   PubMed Web of Science ®Google Scholar
• Garzon R, Calin GA, Croce CM. MicroRNAs in cancer. Annu Rev Med. 2009;60(1):167–179. doi:10.1146/annurev-pathol-012513-104715.
   PubMed Web of Science ®Google Scholar
• Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell. 2009;136(4):586–591. doi:10.1016/j.cell.2009.02.005.
   PubMed Web of Science ®Google Scholar
• Garofalo M, Condorelli G, Croce C, Condorelli G. MicroRNAs as regulators of death receptors signaling. Cell Death Differ. 2010;17(2):200. doi:10.1038/cdd.2009.105.
   PubMed Web of Science ®Google Scholar
• Zhu J, Zou Z, Nie P, Kou X, Wu B, Wang S, et al. Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression. Cell Death Dis. 2016;7(11):e2454. doi:10.1038/cddis.2016.361.
   PubMed Web of Science ®Google Scholar
• Takahashi R-U, Miyazaki H, Ochiya T. The roles of microRNAs in breast cancer. Cancers. 2015;7(2):598–616. doi:10.1038/cdd.2009.
   PubMed Web of Science ®Google Scholar
• Li J, Han L, Roebuck P, Diao L, Liu L, Yuan Y, et al. TANRIC: an interactive open platform to explore the function of lncRNAs in cancer. Cancer Res. 2015;75(18):3728–3737. doi:10.1158/0008-5472.CAN-15-0273.
   PubMed Web of Science ®Google Scholar
• Ádám N, András L, Otília M, Balázs G. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep. 2018;8(1):9227. doi:10.1038/s41598-018-27521-y.
   PubMedGoogle Scholar
• Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136(4):629–641. doi:10.1016/j.cell.2009.02.006.
   PubMed Web of Science ®Google Scholar
• Batista PJ, Chang HY. Long noncoding RNAs: cellular address codes in development and disease. Cell. 2013;152(6):1298–1307. doi:10.1016/j.cell.2013.02.012.
   PubMed Web of Science ®Google Scholar
• Wang L, Luan T, Zhou S, Lin J, Yang Y, Liu W, et al. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p. Cancer Med. 2019;8(9):4389–4403. doi:10.1002/cam4.2335.
   PubMed Web of Science ®Google Scholar
• Youness RA, Hafez HM, Khallaf E, Assal RA, Abdel Motaal A, Gad MZ. The long noncoding RNA sONE represses triple-negative breast cancer aggressiveness through inducing the expression of miR-34a, miR-15a, miR-16, and let-7a. J Cell Physiol. 2019;234(11):20286–20297. doi:10.1002/jcp.28629.
   PubMed Web of Science ®Google Scholar
• Obradovic MMS, Hamelin B, Manevski N, Couto JP, Sethi A, Coissieux MM. Glucocorticoids promote breast cancer metastasis. Nature. 2019;567(7749):540–544. doi:10.1038/s41586-019-1019-4.
   PubMed Web of Science ®Google Scholar
• Weigelt B, Peterse JL, Van’t Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer. 2005;5(8):591. doi:10.1038/nrc1670.
   PubMed Web of Science ®Google Scholar
• Pearson JC, Lemons D, McGinnis W. Modulating Hox gene functions during animal body patterning. Nat Rev Genet. 2005;6(12):893. doi:10.1038/nrg1726.
   PubMed Web of Science ®Google Scholar
• Li B, Han H, Song S, Fan G, Xu H, Zhou W, et al. HOXC10 regulates osteogenesis of mesenchymal stromal cells through interaction with its natural antisense transcript lncHOXC-AS3. Stem Cells. 2019;37(2):247–256. doi:10.1002/stem.2925.
   PubMed Web of Science ®Google Scholar
• Wang X, Sun Y, Xu T, Qian K, Huang B, Zhang K, et al. HOXB13 promotes proliferation, migration, and invasion of glioblastoma through transcriptional upregulation of lncRNA HOXC-AS3. J Cell Biochem. 2019;120(9):15527–15537. doi:10.1002/jcb.28819.
   PubMed Web of Science ®Google Scholar
• Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta. 2014;1839(11):1097–1109. doi:10.1016/j.bbagrm.2014.08.012.
   PubMed Web of Science ®Google Scholar
• Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21(11):1253. doi:10.1038/nm.3981.
   PubMed Web of Science ®Google Scholar
• Connor JH, Weiser DC, Li S, Hallenbeck JM, Shenolikar S. Growth arrest and DNA damage-inducible protein GADD34 assembles a novel signaling complex containing protein phosphatase 1 and inhibitor 1. Mol Cell Bio. 2001;21(20):6841–6850. doi:10.1128/MCB.21.20.6841-6850.
   PubMed Web of Science ®Google Scholar
• Luo W, Xu C, Ayello J, Dela Cruz F, Rosenblum JM, Lessnick SL, et al. Protein phosphatase 1 regulatory subunit 1A in Ewing sarcoma tumorigenesis and metastasis. Oncogene. 2018;37(6):798–809. doi:10.1038/onc.2017.378.
   PubMed Web of Science ®Google Scholar
• Nicolaou P, Hajjar RJ, Kranias EG. Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology. J Mol Cell Cardiol. 2009;47(3):365–371. doi:10.1016/j.yjmcc.
   PubMed Web of Science ®Google Scholar
• Luo W, Xu C, Ayello J, Cruz FD, Rosenblum J, Lessnick S, et al. Protein phosphatase 1 regulatory subunit 1A (PPP1R1A) promotes tumor growth and metastasis via inhibition of protein phosphatase 1 in Ewing sarcoma. Cancer Res. 2016;76(14). doi:10.1158/1538-7445.AM2016-544.
   Google Scholar